Healthcare -
Drug Manufacturers - General - NASDAQ - US
$ 141.61
0.79 %
$ 20.7 B
Market Cap
12.67
P/E
BIIB - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities BIIB - Biogen Inc.
-684 M
LAST VALUE
37.68%
2 YEAR CAGR
34.93%
5 YEAR CAGR
1.00%
10 YEAR CAGR